Better Patient Care Through Innovation

 

Breaking News

On June 10, 2019, Insys Therapeutics, Inc. filed petitions seeking relief under chapter 11 of the United States Bankruptcy Code.

If you believe you have a potential claim against Insys, please click ‘Read More' below for further information on completing a proof of claim. SEPTEMBER 16, 2019 (the “Bar Date”) IS THE DEADLINE for every person or entity (except governmental units and Native American Tribes) to submit a proof of claim.

Read More

About INSYS

Our vision is to improve the quality of patient care by building a specialty pharmaceutical company focused on cannabinoids and novel drug delivery systems that address unmet patient needs.

SCIENCE

We are an innovative organization with a focus on providing therapeutic solutions helping to improve the lives of patients. 

 

SCIENCE

We are an innovative organization with a focus on providing therapeutic solutions helping to improve the lives of patients. 

 

SOCIAL RESPONSIBILITY

Our commitment to better patient care is measured not only by our focus on bringing innovative technologies to patients and physicians, but also by the importance we place on making an impact within the communities where we work and live.

 

SOCIAL RESPONSIBILITY

Our commitment to better patient care is measured not only by our focus on bringing innovative technologies to patients and physicians, but also by the importance we place on making an impact within the communities where we work and live.